Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011109
Filing Date
2024-08-06
Accepted
2024-08-06 16:32:36
Documents
115
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vreof-20240630x10q.htm   iXBRL 10-Q 1812360
2 EX-10.71 vreof-20240630xex10d71.htm EX-10.71 46572
3 EX-10.72 vreof-20240630xex10d72.htm EX-10.72 41127
4 EX-10.73 vreof-20240630xex10d73.htm EX-10.73 53946
5 EX-10.74 vreof-20240630xex10d74.htm EX-10.74 56175
6 EX-10.75 vreof-20240630xex10d75.htm EX-10.75 82831
7 EX-31.1 vreof-20240630xex31d1.htm EX-31.1 17159
8 EX-31.2 vreof-20240630xex31d2.htm EX-31.2 16630
9 EX-32.1 vreof-20240630xex32d1.htm EX-32.1 8867
10 GRAPHIC vreof-20240630xex10d71001.jpg GRAPHIC 803
  Complete submission text file 0001558370-24-011109.txt   9536430

Data Files

Seq Description Document Type Size
11 EX-101.SCH vreof-20240630.xsd EX-101.SCH 80098
12 EX-101.CAL vreof-20240630_cal.xml EX-101.CAL 83139
13 EX-101.DEF vreof-20240630_def.xml EX-101.DEF 288021
14 EX-101.LAB vreof-20240630_lab.xml EX-101.LAB 623170
15 EX-101.PRE vreof-20240630_pre.xml EX-101.PRE 499604
118 EXTRACTED XBRL INSTANCE DOCUMENT vreof-20240630x10q_htm.xml XML 1583368
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 241179898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)